Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)

SHE:300841 Revenue

Chengdu Kanghua Biological Products had revenue of 346.31M CNY in the quarter ending September 30, 2026, a decrease of -2.76%. This brings the company's total for the last twelve months to 1.21B, down -0.16% year-over-year. In the year 2025, Chengdu Kanghua Biological Products had annual revenue of 1.17B, down -18.64%. That makes Chengdu Kanghua Biological Products the 18,185th largest company in the world by revenue and 3,322nd in China.

• Revenue (ttm): 1.21B
• Revenue Growth: -0.16%
• P/S Ratio: 5.52
• Revenue / Employee: 2.20M
• Employees: 550
• Market Cap: 6.68B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biological Products 1.16B 100.0%
• Others 90.80K 0.0%

By Geography

Chart

• East China 485.81M 41.7%
• Central China 209.50M 18.0%
• South China 144.86M 12.4%
• North China 138.60M 11.9%
• Southwest China 110.22M 9.5%
• Northwest China 56.18M 4.8%
• Northeast China 19.82M 1.7%

Fiscal year ended Dec 31, 2025 See the full SHE:300841 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.17B	-266.88M	-18.64%
Dec 31, 2024	1.43B	-145.52M	-9.23%
Dec 31, 2023	1.58B	130.67M	9.03%
Jan 1, 2023	1.45B	154.28M	11.94%
Jan 1, 2022	1.29B	253.81M	24.44%

Data Source: S&P Global Market Intelligence Last updated: Oct 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error